In conclusion, we have generated robust data demonstrating that the use of pharmacologic inhibitors of CAIX activity in combination with anti-angiogenic agents results in the inhibition of tumor growth and reduced lung metastasis in TNBC. Here, CA9 is linked to neoplasm.